A substantial proportion of HER2-negative breast cancer patients had a BRCA-likeCGH tumor (81/249, 32%), which is close to the predicted proportion of BRCAness in sporadic breast cancers (30%) [12]. Here, ERBB2 is linked to breast carcinoma.